Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Myalgia, Nausea, Nervousness, Pruritus
Clinical narrative: bruising; shaky; dizzy; anxiety; rash; confusion - bad injection site clinic; ER Pain in Abdomen; Burning skin; itch; intense bi-lateral muscle, joint pain; intense bi-lateral muscle, joint pain; explosive digestive issues; falling backwards; vision - slow; motion, cognition issues; fever; Chills; Nausea; Inflammation; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 12Apr2021 12:00 (Lot number: EP7533) at the age of 73 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Extensive FMS" (unspecified if ongoing); "Extensive CF" (unspecified if ongoing); "Angiodema" (unspecified if ongoing); "cough" (unspecified if ongoing); "Asthma" (unspecified if ongoing); "IBS" (unspecified if ongoing); "known_allergies: Multiple meds including Gycol-PEG" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: CONTUSION (non-serious) with onset Apr2021, outcome "recovering", described as "bruising"; NERVOUSNESS (non-serious) with onset Apr2021, outcome "recovering", described as "shaky"; DIZZINESS (non-serious) with onset Apr2021, outcome "recovering", described as "dizzy"; ANXIETY (non-serious) with onset Apr2021, outcome "recovering", described as "anxiety"; RASH (non-serious) with onset Apr2021, outcome "recovering", described as "rash"; CONFUSIONAL STATE (non-serious) with onset Apr2021, outcome "recovering", described as "confusion - bad injection site clinic"; ABDOMINAL PAIN (non-serious) with onset Apr2021, outcome "recovering", described as "ER Pain in Abdomen"; SKIN BURNING SENSATION (non-serious) with onset Apr2021, outcome "recovering", described as "Burning skin"; PRURITUS (non-serious) with onset Apr2021, outcome "recovering", described as "itch"; MYALGIA (non-serious), ARTHRALGIA (non-serious) all with onset Apr2021, outcome "recovering" and all described as "intense bi-lateral muscle, joint pain"; DIGESTIVE ENZYME ABNORMAL (non-serious) with onset Apr2021, outcome "recovering", described as "explosive digestive issues"; FALL (non-serious) with onset Apr2021, outcome "recovering", described as "falling backwards"; VISUAL IMPAIRMENT (non-serious) with onset Apr2021, outcome "recovering", described as "vision - slow "; COGNITIVE DISORDER (non-serious) with onset Apr2021, outcome "recovering", described as "motion, cognition issues"; PYREXIA (non-serious) with onset Apr2021, outcome "recovering", described as "fever"; CHILLS (non-serious) with onset Apr2021, outcome "recovering", described as "Chills"; NAUSEA (non-serious) with onset Apr2021, outcome "recovering", described as "Nausea"; INFLAMMATION (non-serious) with onset Apr2021, outcome "recovering", described as "Inflammation". The events "bruising", "shaky", "dizzy", "anxiety", "rash", "confusion - bad injection site clinic", "er pain in abdomen", "burning skin", "itch", "intense bi-lateral muscle, joint pain", "intense bi-lateral muscle, joint pain", "explosive digestive issues", "falling backwards", "vision - slow ", "motion, cognition issues", "fever", "chills", "nausea" and "inflammation" were evaluated at the physician office visit and emergency room visit. Therapeutic measures were not taken as a result of contusion, nervousness, dizziness, anxiety, rash, confusional state, abdominal pain, skin burning sensation, pruritus, myalgia, arthralgia, digestive enzyme abnormal, fall, visual impairment, cognitive disorder, pyrexia, chills, nausea, inflammation.  Additional information: Patient had not taken other vaccine in four weeks. The patient had taken other medications in two weeks. Was seen at site clinic. She tried to ask for Glycol. Rushed through. No Covid prior vaccination. The patient was not tested for Covid post vaccination. Device timestamp was reported as 06Oct2021.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101336847 same reporter/patient/product, different dose/event.